CREST-2 trial: Determining the best treatment for carotid atherosclerotic stenosis Sept. 18, 2014 Overview Show transcript Overview Kevin M. Barrett, M.D., vascular neurologist at Mayo Clinic's campus in Florida, talks about the second phase of the international stroke trial and how to refer patients for participation. Dr. Barrett shares information about the seven-year clinical trial that aims to enroll 2,480 patients in 120 centers in the U.S., Canada, Europe and Australia to address interventional and medical therapies. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related Content Q and ACREST-2 update: Enrolling patients for optimal careVideoCarotid artery disease with stenosis diagnosis and treatment optionsArticleCarotid plaque imaging spurs innovative care VID-20433531 Medical Professionals CREST-2 Trial: Determining the Best Treatment for Carotid Atherosclerotic Stenosis